Skip to main content

Table 1 Demographic and clinical data

From: Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma

 

n

Age enrolled in our study (month)

Gender (female/male)

Tumor stage

Treatment before serum collection

Healthy children

10

41.9 ± 1.7

5/5

–

–

NB

20

44.5 ± 6.4

9/11

I: 4

II: 9

III: 6

IV: 1

13 children: no treatment

7 children: chemotherapy, receiving vincristine, cyclophosphamide, adriamycin, etoposide, and cisplatin

OMS + NB

10

35.6 ± 9.9

5/5

I: 3

II: 4

III: 3

IV: 0

8 children: no treatment

1 child: steroid

1 child: intravenous immune globulin

Juvenile idiopathic arthritis (JIA)

10

40.8 ± 10.5

6/4

–

6 children: no treatment

3 children: nonsteroidal anti-inflammatory drugs

1 child: received steroid

Anti-NDMAR encephalitis

6

54.3 ± 9.9

4/2

–

2 children: no treatment

4 children: steroid and intravenous immune globulin